FOXL2 and blepharophimosis, ptosis, and epicanthus inversus syndrome: Therefore, identification of novel FOXL2 mutations and further characterization of their contributions to the pathogenesis of BPES will provide not only biomarkers for early detection of BPES but also potential implications for therapeutic intervention.